Overview
FTRE market data
Price HistoryDaily closing bars from the ranked market-data provider chain, not a live tape. The most recent bar is the last completed session, so it lags an open market.
FTRE price chart · 1M
- O
- 24.40
- H
- 26.08
- L
- 24.39
- C
- 25.93
- Vol
- 184,975.00
Daily history from Jun 23, 2023
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $24.40
- Previous Close
- $24.44
- Day High
- $26.08
- Day Low
- $24.39
- 52 Week High
- $26.08
- 52 Week Low
- $8.57
- 7 Day Return
- +7.77%
- 30 Day Return
- +29.39%
- 90 Day Return
- +35.94%
- 1 Year Return
- +144.62%
- Daily Notional Volume
- $4.8M Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$10.81 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.91 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.55 – $24.84 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.3B · P/B 2.83 · P/S 0.87.
Company NewsSymbol-tagged NewsEvent via getLatestNewsEventsBySymbol (Prisma first, Redis news:latest:v2 fallback). Operator cap 12 / public 10; low-signal filtered, headlines deduped. Display-only—scored signals stay on the separate signals surface.
10 captured
Collaboration entre Fortrea et Omico pour faire progresser le développement de médicaments oncologiques basés sur des biomarqueursGlobenewswire Inc ·
Fortrea 與 Omico 攜手合作,推動生物標記主導的腫瘤藥物開發Globenewswire Inc ·
Fortrea und Omico kooperieren zur Förderung der biomarkergestützten Entwicklung von KrebsmedikamentenGlobenewswire Inc ·
Fortrea 与 Omico 携手,推进生物标志物导向的肿瘤药物开发Globenewswire Inc ·
フォートリアとオミコ、バイオマーカー主導の抗がん剤開発推進に向けて提携Globenewswire Inc ·
Kolaborasi Fortrea dan Omico untuk Mendorong Pengembangan Obat Onkologi Berbasis BiomarkerGlobenewswire Inc ·
שיתוף פעולה בין Fortrea ל-Omico לקידום פיתוח תרופות אונקולוגיות המבוססות על סמנים ביולוגייםGlobenewswire Inc ·
포트리아와 오미코, 바이오마커 기반 항암 신약 개발 발전 위한 협력 추진Globenewswire Inc ·